Game-Set-MATCH: Liquid Biopsy Advances to the Next Round

A recent article evaluated the concordance rate between tumor and plasma genotyping for detecting actionable genomic alterations to guide targeted therapy. These results support the utility of liquid biopsy for enrolling patients into genomically guided trials, especially in scenarios in which tissue is unavailable or biopsy is not feasible.